Clinical School (St Vincent's Hospital)
Collections in this community
(SPRINGER HEIDELBERG, 2017-12-01)
(SPRINGER, 2014-04-01)There has been considerable recent interest in the genetic, biological and epidemiological basis of mammographic density (MD), and the search for causative links between MD and breast cancer (BC) risk. This report will ...
Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study (SPRINGER, 2013-10-01)Hormone receptor-positive breast cancer is treated with estrogen inhibitors. Fulvestrant (FASLODEX™), an estrogen receptor (ER) antagonist with no known agonist effects, competitively binds, blocks and degrades the ER. ...